Invention Grant
US09241983B2 Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
有权
解脲支原体疫苗和预防和治疗人类，动物和细胞培养感染的抗体
- Patent Title: Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
- Patent Title (中): 解脲支原体疫苗和预防和治疗人类，动物和细胞培养感染的抗体
-
Application No.: US14114703Application Date: 2012-04-30
-
Publication No.: US09241983B2Publication Date: 2016-01-26
- Inventor: Leonard Weisman , Lingkun Kong
- Applicant: Leonard Weisman , Lingkun Kong
- Applicant Address: US TX Houston
- Assignee: Baylor College of Medicine
- Current Assignee: Baylor College of Medicine
- Current Assignee Address: US TX Houston
- Agency: Williams Mullen PC
- Agent David Kulik
- International Application: PCT/US2012/035779 WO 20120430
- International Announcement: WO2012/149525 WO 20121101
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/395 ; A61K39/00
Abstract:
The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma, including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of Ureaplasma.
Public/Granted literature
- US20140065195A1 UREAPLASMA VACCINE AND ANTIBODY FOR PREVENTION AND TREATMENT OF HUMAN, ANIMAL AND CELL CULTURE INFECTION Public/Granted day:2014-03-06
Information query
